NDC 55289-920-98
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-920
- Requested NDC
- 55289-920-98
- Package NDCs from labels
- 55289-920-98
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-920-06 | EA - Each | 55289-920 | 706d0221-1af2-41d4-9df2-bf37b14b690f | 1 | 2012-07-24 |
| 55289-920-30 | EA - Each | 55289-920 | 29427292-7c0b-4173-859f-ff32c417f2e7 | 1 | 2012-07-24 |
| 55289-920-40 | EA - Each | 55289-920 | 27fb6d9e-1de6-4d20-a60e-6518e959ca62 | 1 | 2012-07-24 |
| 55289-920-60 | EA - Each | 55289-920 | d88ef8cb-70eb-456a-8133-6265354cbc4a | 1 | 2012-07-24 |
| 55289-920-90 | EA - Each | 55289-920 | cd4fb9c8-ca98-40b2-8d76-5faca8c9fb4e | 1 | 2012-07-24 |
| 55289-920-98 | EA - Each | 55289-920 | 2a336a9c-9f8d-4b3f-8c19-cc8e37318b9d | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SILDENAFIL CITRATE | SILDENAFIL | PD-Rx Pharmaceuticals, Inc. | 78c4551c-b922-43c9-9a5a-66377ea07bc2 | 2026-05-27 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Naproxen Sodium | NAPROXEN SODIUM | PD-Rx Pharmaceuticals, Inc. | c5146d73-2f34-4dfe-ac29-97071279dc4d | 2026-05-26 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| Bupropion Hydrochloride SR | BUPROPION HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | f58ce435-b124-4519-98d8-de2d00f61b01 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | ea1527a5-4939-4ff7-a827-f88a9113a07d | 2026-05-26 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| clonidine hydrochloride | CLONIDINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | be1b921d-152e-4bd5-82bd-56e2f8beef3e | 2026-05-26 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Etodolac | ETODOLAC | PD-Rx Pharmaceuticals, Inc. | 007c55fa-ef8b-4a8e-bfe5-e47c6e5da727 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 5ce082e9-13eb-4e63-a9e2-657d3ef0e9f8 | 2026-05-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | f93ca67d-362a-473f-8296-2952da77c074 | 2026-05-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | b0ba50da-9f70-4531-a9de-3dd3f8aa1f5d | 2026-05-22 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| METFORMIN HYDROCHLORIDE EXTENDED RELEASE | METFORMIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | d1d7204a-7e8a-4f76-bf9f-3e798c2632ba | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Indomethacin | INDOMETHACIN | PD-Rx Pharmaceuticals, Inc. | ce866d3a-7bea-4d82-9b7d-79e8a294c141 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Indomethacin | INDOMETHACIN | PD-Rx Pharmaceuticals, Inc. | d66ada00-3ece-4b71-8c59-a0db48a2db80 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | PD-Rx Pharmaceuticals, Inc. | 2ded7e5e-c377-4495-a045-f1c57b90c5db | 2026-05-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | PD-Rx Pharmaceuticals, Inc. | 46fdf929-c961-4dd9-8865-8eb4adaa259a | 2026-05-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Celecoxib | CELECOXIB | PD-Rx Pharmaceuticals, Inc. | 52572bfb-43f0-4b55-b1fd-231a05c8b83e | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Dicloxacillin Sodium | DICLOXACILLIN SODIUM | PD-Rx Pharmaceuticals, Inc. | c17cd62d-ff5d-47ba-8673-3346c7f2365f | 2026-05-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Junel Fe 28 Day | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | PD-Rx Pharmaceuticals, Inc. | 93a2f8c9-3550-42ec-8f76-3ac9badf4bb2 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metoprolol Tartrate | METOPROLOL TARTRATE | PD-Rx Pharmaceuticals, Inc. | ab44f4c5-9497-4c92-8545-e4718ddb8f08 | 2026-05-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | abb56236-f2fe-45b5-93ac-35fd661f8992 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Spironolactone | SPIRONOLACTONE | PD-Rx Pharmaceuticals, Inc. | c223a334-7383-429f-b8e3-a21200f16962 | 2026-05-21 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.